Showing results (371-380 of 399) with videos related to
Sort By:
Pageof 40
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 23, 2006
A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activationYoon Seong Kim, Dong Hee Choi, Michelle L Block, et al.Frontiers in Physiology|August 1, 2014
Protective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunctionIstvan Czikora, Supriya Sridhar, Boris Gorshkov, et al.The Lancet. Infectious Diseases|September 6, 2020
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trialJudith Absalon, Nathan Segall, Stan L Block, et al.The Journal of Infectious Diseases|March 18, 2000
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccineR B Belshe, W C Gruber, P M Mendelman, et al.Proceedings of the National Academy of Sciences of the United States of America|December 9, 2016
Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signalingJinfeng Gan, Xiurong Ke, Jiali Jiang, et al.Proceedings of the National Academy of Sciences of the United States of America|December 29, 2011
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Ferenc G Rick, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2010
Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllersZabrina L Brumme, Chun Li, Toshiyuki Miura, et al.The Journal of Pediatrics|February 5, 2000
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineR B Belshe, W C Gruber, P M Mendelman, et al.The Lancet. Infectious Diseases|June 16, 2025
Safety and immunogenicity of a booster dose of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 2, open-label extension of a phase 1/2 randomised controlled trialBabalwa Jongihlati, Nathan Segall, Stanley L Block, et al.Cell Reports|August 4, 2022
Prenatal environmental stressors impair postnatal microglia function and adult behavior in malesCarina L Block, Oznur Eroglu, Stephen D Mague, et al.Pageof 40